Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 69

1.

Fluoroquinolone-Resistant Streptococcus agalactiae Invasive Isolates Recovered in Argentina.

Arias B, Kovacec V, Vigliarolo L, Suárez M, Tersigni C, Müller L, Lopardo H, Bonofiglio L, Mollerach M.

Microb Drug Resist. 2019 Jun;25(5):739-743. doi: 10.1089/mdr.2018.0246. Epub 2019 Jan 24.

PMID:
30676886
2.

[Susceptibility of Streptococcus pyogenes isolated from invasive infections to trimethoprim-sulfamethoxazole].

Vigliarolo L, Gazzeli L, Bonofiglio L, Mollerach M, Lopardo H.

Medicina (B Aires). 2018;78(5):311-314. Spanish.

3.

Resistance to β-lactams in enterococci.

Gagetti P, Bonofiglio L, García Gabarrot G, Kaufman S, Mollerach M, Vigliarolo L, von Specht M, Toresani I, Lopardo HA.

Rev Argent Microbiol. 2019 Apr - Jun;51(2):179-183. doi: 10.1016/j.ram.2018.01.007. Epub 2018 Sep 20.

4.

Streptococcus pneumoniae galU gene mutation has a direct effect on biofilm growth, adherence and phagocytosis in vitro and pathogenicity in vivo.

Cools F, Torfs E, Vanhoutte B, de Macedo MB, Bonofiglio L, Mollerach M, Maes L, Caljon G, Delputte P, Cappoen D, Cos P.

Pathog Dis. 2018 Oct 1;76(7). doi: 10.1093/femspd/fty069.

PMID:
30215741
5.

TNFR1 Signaling Contributes to T Cell Anergy During Staphylococcus aureus Sepsis.

Ledo C, Gonzalez CD, Poncini CV, Mollerach M, Gómez MI.

Front Cell Infect Microbiol. 2018 Aug 3;8:259. doi: 10.3389/fcimb.2018.00259. eCollection 2018.

6.

Susceptibility to β-lactams in β-hemolytic streptococci.

Bonofiglio L, Gagetti P, García Gabarrot G, Kaufman S, Mollerach M, Toresani I, Vigliarolo L, von Specht M, Lopardo HA.

Rev Argent Microbiol. 2018 Oct - Dec;50(4):431-435. doi: 10.1016/j.ram.2017.11.002. Epub 2018 Mar 13.

7.

Molecular Epidemiology of Methicillin-Resistant Staphylococcus aureus in Cystic Fibrosis Patients from Argentina.

Pena Amaya P, Haim MS, Fernández S, Di Gregorio S, Teper A, Vázquez M, Lubovich S, Galanternik L, Mollerach M.

Microb Drug Resist. 2018 Jun;24(5):613-620. doi: 10.1089/mdr.2017.0162. Epub 2017 Nov 29.

PMID:
29185854
8.

Anatomy and histology of the prostate and glands of Cowper in three species of neotropical bats.

Miotti MD, Mollerach MI, Barquez RM.

J Morphol. 2018 Mar;279(3):294-301. doi: 10.1002/jmor.20771. Epub 2017 Nov 9.

PMID:
29119604
9.

First description of rpsJ and mepA mutations associated with tigecycline resistance in Staphylococcus aureus isolated from a cystic fibrosis patient during antibiotic therapy.

Haim MS, Di Gregorio S, Galanternik L, Lubovich S, Vázquez M, Bharat A, Zaheer R, Golding GR, Graham M, Van Domselaar G, Cardona ST, Mollerach M.

Int J Antimicrob Agents. 2017 Dec;50(6):739-741. doi: 10.1016/j.ijantimicag.2017.10.003. Epub 2017 Oct 13. No abstract available.

PMID:
29038088
10.

High virulence of methicillin resistant Staphylococcus aureus ST30-SCCmecIVc-spat019, the dominant community-associated clone in Argentina.

Fernandez S, Ledo C, Lattar S, Noto Llana M, Bertelli AM, Di Gregorio S, Sordelli DO, Gómez MI, Mollerach ME.

Int J Med Microbiol. 2017 Jun;307(4-5):191-199. doi: 10.1016/j.ijmm.2017.05.003. Epub 2017 May 15.

PMID:
28549830
11.

[Description of 3 cases of skin and soft tissue infections caused by Streptococcus pneumoniae].

Martínez ME, Grenón SL, López OH, Leguizamón LB, Mollerach ME, von Specht MH.

Rev Argent Microbiol. 2017 Apr - Jun;49(2):142-145. doi: 10.1016/j.ram.2016.12.005. Epub 2017 Apr 14. Spanish.

12.

Group B streptococcal necrotizing pneumonia in a diabetic adult patient.

Pacha A, Luna Cian R, Bonofiglio L, Solari M, Strada V, Suárez M, Vigliarolo L, Tersigni C, Mollerach M, Lopardo H.

Rev Argent Microbiol. 2017 Apr - Jun;49(2):139-141. doi: 10.1016/j.ram.2016.09.005. Epub 2017 Mar 18.

13.

Screening assay for inhibitors of a recombinant Streptococcus pneumoniae UDP-glucose pyrophosphorylase.

Zavala A, Kovacec V, Levín G, Moglioni A, Miranda MV, García E, Bonofiglio L, Mollerach M.

J Enzyme Inhib Med Chem. 2017 Dec;32(1):203-207. doi: 10.1080/14756366.2016.1247055.

14.

Antimicrobial susceptibility of clinical isolates of Actinomyces and related genera reveals an unusual clindamycin resistance among Actinomyces urogenitalis strains.

Barberis C, Budia M, Palombarani S, Rodriguez CH, Ramírez MS, Arias B, Bonofiglio L, Famiglietti A, Mollerach M, Almuzara M, Vay C.

J Glob Antimicrob Resist. 2017 Mar;8:115-120. doi: 10.1016/j.jgar.2016.11.007. Epub 2017 Jan 18.

PMID:
28109846
15.

Different Vancomycin-Intermediate Staphylococcus aureus Phenotypes Selected from the Same ST100-hVISA Parental Strain.

Di Gregorio S, Fernandez S, Cuirolo A, Verlaine O, Amoroso A, Mengin-Lecreulx D, Famiglietti A, Joris B, Mollerach M.

Microb Drug Resist. 2017 Jan;23(1):44-50. doi: 10.1089/mdr.2016.0160. Epub 2016 Dec 19.

16.

Draft Genome Sequences of Burkholderia contaminans FFI-28, a Strain Isolated from a Contaminated Pharmaceutical Solution.

Haim MS, Mollerach M, Van Domselaar G, Teves SA, Degrossi J, Cardona ST.

Genome Announc. 2016 Oct 27;4(5). pii: e01177-16. doi: 10.1128/genomeA.01177-16.

17.

Increase in IS256 transposition in invasive vancomycin heteroresistant Staphylococcus aureus isolate belonging to ST100 and its derived VISA mutants.

Di Gregorio S, Fernandez S, Perazzi B, Bello N, Famiglietti A, Mollerach M.

Infect Genet Evol. 2016 Sep;43:197-202. doi: 10.1016/j.meegid.2016.05.001. Epub 2016 May 3.

PMID:
27154328
18.

In vitro selection of Staphylococcus aureus mutants resistant to tigecycline with intermediate susceptibility to vancomycin.

Herrera M, Di Gregorio S, Fernandez S, Posse G, Mollerach M, Di Conza J.

Ann Clin Microbiol Antimicrob. 2016 Mar 8;15:15. doi: 10.1186/s12941-016-0131-7.

19.

Community-acquired necrotizing pneumonia caused by methicillin-resistant Staphylococcus aureus ST30-SCCmecIVc-spat019-PVL positive in San Antonio de Areco, Argentina.

Fernandez S, Murzicato S, Sandoval O, Fernández-Canigia L, Mollerach M.

Rev Argent Microbiol. 2015 Jan-Mar;47(1):50-3. doi: 10.1016/j.ram.2014.11.002. Epub 2015 Feb 11.

20.

Clinical, microbiological, and genetic characteristics of heteroresistant vancomycin-intermediate Staphylococcus aureus bacteremia in a teaching hospital.

Di Gregorio S, Perazzi B, Ordoñez AM, De Gregorio S, Foccoli M, Lasala MB, García S, Vay C, Famiglietti A, Mollerach M.

Microb Drug Resist. 2015 Feb;21(1):25-34. doi: 10.1089/mdr.2014.0190. Epub 2014 Dec 23.

21.

Community-associated methicillin-resistant Staphylococcus aureus skin and soft tissue infections in a pediatric hospital in Argentina.

von Specht MH, Gardella N, Ubeda C, Grenon S, Gutkind G, Mollerach M.

J Infect Dev Ctries. 2014 Sep 12;8(9):1119-28. doi: 10.3855/jidc.4271.

22.

Genetic environment of the lnu(B) gene in a Streptococcus agalactiae clinical isolate.

Montilla A, Zavala A, Cáceres Cáceres R, Cittadini R, Vay C, Gutkind G, Famiglietti A, Bonofiglio L, Mollerach M.

Antimicrob Agents Chemother. 2014 Sep;58(9):5636-7. doi: 10.1128/AAC.02630-14. Epub 2014 Jun 23. No abstract available.

23.

Prospective multicenter study of community-associated skin and skin structure infections due to methicillin-resistant Staphylococcus aureus in Buenos Aires, Argentina.

López Furst MJ, de Vedia L, Fernández S, Gardella N, Ganaha MC, Prieto S, Carbone E, Lista N, Rotryng F, Morera GI, Mollerach M, Stryjewski ME; Grupo de Estudio de Infecciones de Piel y Estructuras Relacionadas por Staphylococcus aureus meticilino-resistente de la Comunidad, Sociedad Argentina de Infectología.

PLoS One. 2013 Nov 20;8(11):e78303. doi: 10.1371/journal.pone.0078303. eCollection 2013.

24.

First case of Streptococcus lutetiensis bacteremia involving a clindamycin-resistant isolate carrying the lnuB gene.

Almuzara M, Bonofiglio L, Cittadini R, Vera Ocampo C, Montilla A, Del Castillo M, Ramirez MS, Mollerach M, Vay C.

J Clin Microbiol. 2013 Dec;51(12):4259-61. doi: 10.1128/JCM.01774-13. Epub 2013 Sep 18.

25.

Methicillin-resistant Staphylococcus aureus ST30-SCCmec IVc clone as the major cause of community-acquired invasive infections in Argentina.

Fernandez S, de Vedia L, Lopez Furst MJ, Gardella N, Di Gregorio S, Ganaha MC, Prieto S, Carbone E, Lista N, Rotrying F, Stryjewski ME, Mollerach M.

Infect Genet Evol. 2013 Mar;14:401-5. doi: 10.1016/j.meegid.2012.12.018. Epub 2013 Jan 20.

PMID:
23340226
26.

Community-associated methicillin-resistant Staphylococcus aureus in children treated in Uruguay.

Pardo L, Vola M, Macedo-Viñas M, Machado V, Cuello D, Mollerach M, Castro M, Pírez C, Varela G, Algorta G.

J Infect Dev Ctries. 2013 Jan 15;7(1):10-6. doi: 10.3855/jidc.2261.

27.

[Two multidrug-resistant Salmonella infantis isolates behave like hypo-invasive strains but have high intracellular proliferation].

Di Conza JA, Mollerach ME, Gutkind GO, Ayala JA.

Rev Argent Microbiol. 2012 Apr-Jun;44(2):69-74. Spanish.

PMID:
22997763
28.

The length of the Staphylococcus aureus protein A polymorphic region regulates inflammation: impact on acute and chronic infection.

Garofalo A, Giai C, Lattar S, Gardella N, Mollerach M, Kahl BC, Becker K, Prince AS, Sordelli DO, Gómez MI.

J Infect Dis. 2012 Jul 1;206(1):81-90. doi: 10.1093/infdis/jis311. Epub 2012 Apr 25.

PMID:
22535996
29.

The galU gene expression in Streptococcus pneumoniae.

Bonofiglio L, García E, Mollerach M.

FEMS Microbiol Lett. 2012 Jul;332(1):47-53. doi: 10.1111/j.1574-6968.2012.02572.x. Epub 2012 Apr 27.

30.

[Comparative study of clones from isolates methicillin-resistant Staphylococcus aureus prevalent in Argentina].

Gardella N, Fernandez S, Di Gregorio S, Cuirolo A, Gutkind G, Mollerach M.

Rev Panam Salud Publica. 2011 Dec;30(6):665-6. Spanish. No abstract available.

PMID:
22358420
31.

Endocarditis caused by methicillin-susceptible Staphylococcus aureus with reduced susceptibility to vancomycin: a case report.

Perazzi B, Bello N, Mollerach M, Vay C, Lasala MB, Famiglietti A.

J Med Case Rep. 2011 Nov 25;5:555. doi: 10.1186/1752-1947-5-555. No abstract available.

32.

Hyperendemic clone of KPC producing Klebsiellapneumoniae ST 258 in Buenos Aires hospitals.

Cejas D, Fernandez Canigia L, Nastro M, Rodríguez C, Tanco A, Rodríguez H, Vay C, Maldonado I, Famiglietti A, Giovanakis M, Magariños F, Berardinelli E, Neira L, Mollerach M, Gutkind G, Radice M.

Infect Genet Evol. 2012 Apr;12(3):499-501. doi: 10.1016/j.meegid.2011.09.018. Epub 2011 Oct 1. No abstract available.

PMID:
21986471
33.

Endocarditis caused by methicillin-susceptible Staphylococcus aureus with reduced susceptibility to vancomycin: a case report.

Perazzi B, Bello N, Mollerach M, Vay C, Lasala MB, Famiglietti A.

J Med Case Rep. 2011 Jul 7;5:292. doi: 10.1186/1752-1947-5-292.

34.

Prevalence and characterization of methicillin-resistant Staphylococcus aureus among healthy children in a city of Argentina.

Gardella N, Murzicato S, Di Gregorio S, Cuirolo A, Desse J, Crudo F, Gutkind G, Mollerach M.

Infect Genet Evol. 2011 Jul;11(5):1066-71. doi: 10.1016/j.meegid.2011.03.019. Epub 2011 Apr 2.

PMID:
21463711
35.

Oxacillin- and cefoxitin-susceptible meticillin-resistant Staphylococcus aureus (MRSA).

Cuirolo A, Canigia LF, Gardella N, Fernández S, Gutkind G, Rosato A, Mollerach M.

Int J Antimicrob Agents. 2011 Feb;37(2):178-9. doi: 10.1016/j.ijantimicag.2010.10.017. Epub 2010 Dec 15. No abstract available.

PMID:
21163627
36.

Dissemination of an erythromycin-resistant penicillin-nonsusceptible Streptococcus pneumoniae Poland(6B)-20 clone in Argentina.

Bonofiglio L, Regueira M, Pace J, Corso A, García E, Mollerach M.

Microb Drug Resist. 2011 Mar;17(1):75-81. doi: 10.1089/mdr.2010.0027. Epub 2010 Dec 4.

PMID:
21128835
37.

Multicenter study for defining the breakpoint for rifampin resistance in Neisseria meningitidis by rpoB sequencing.

Taha MK, Hedberg ST, Szatanik M, Hong E, Ruckly C, Abad R, Bertrand S, Carion F, Claus H, Corso A, Enríquez R, Heuberger S, Hryniewicz W, Jolley KA, Kriz P, Mollerach M, Musilek M, Neri A, Olcén P, Pana M, Skoczynska A, Sorhouet Pereira C, Stefanelli P, Tzanakaki G, Unemo M, Vázquez JA, Vogel U, Wasko I.

Antimicrob Agents Chemother. 2010 Sep;54(9):3651-8. doi: 10.1128/AAC.00315-10. Epub 2010 Jul 6.

38.

Characteristics of Community-Associated Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Strains Isolated from Skin and Soft-Tissue Infections in Uruguay.

Pardo L, Machado V, Mollerach M, Mota MI, Tuchscherr LP, Gadea P, Gardella N, Sordelli DO, Vola M, Schelotto F, Varela G.

Int J Microbiol. 2009;2009:472126. doi: 10.1155/2009/472126. Epub 2009 Oct 22.

39.

Community-associated methicillin-resistant Staphylococcus aureus, eastern Argentina.

Gardella N, von Specht M, Cuirolo A, Rosato A, Gutkind G, Mollerach M.

Diagn Microbiol Infect Dis. 2008 Nov;62(3):343-7. doi: 10.1016/j.diagmicrobio.2008.07.008. Epub 2008 Aug 19.

PMID:
18715738
40.

PorA types in Neisseria meningitidis serogroup B isolated in Argentina from 2001 to 2003: implications for the design of an outer membrane protein-based vaccine.

Sorhouet Pereira C, Regueira M, Mollerach M.

J Med Microbiol. 2008 Mar;57(Pt 3):338-42. doi: 10.1099/jmm.0.47631-0.

PMID:
18287297
41.

[Community-acquired methicillin-resistant Staphylococcus aureus infections in a hospital for acute diseases].

Palombarani S, Gardella N, Tuduri A, Figueroa S, Sly G, Corazza R, Gutkind G, Almuzara M, Mollerach M.

Rev Argent Microbiol. 2007 Jul-Sep;39(3):151-5. Spanish.

PMID:
17987851
42.

[Surveillance of Neisseria meningitidis in Argentina, 1993-2005: distribution of serogroups, serotypes and serosubtypes isolated from invasive disease].

Chiávetta L, Chávez E, Ruzic A, Mollerach M, Regueira M.

Rev Argent Microbiol. 2007 Jan-Mar;39(1):21-7. Spanish.

PMID:
17585655
43.

[Genomics and proteomics: opportunities and challenges for microbiology].

Mollerach M.

Rev Argent Microbiol. 2006 Jan-Mar;38(1):1-3. Spanish. No abstract available.

PMID:
16784124
44.

Methicillin-resistant Staphylococcus aureus in community-acquired meningitis.

von Specht M, Gardella N, Tagliaferri P, Gutkind G, Mollerach M.

Eur J Clin Microbiol Infect Dis. 2006 Apr;25(4):267-9. No abstract available.

PMID:
16570137
45.

Molecular characterization of InJR06, a class 1 integron located in a conjugative plasmid of Salmonella enterica ser. Typhimurium.

Di Conza J, Ayala JA, Porto A, Mollerach M, Gutkind G.

Int Microbiol. 2005 Dec;8(4):287-90.

46.

[PCR-based capsular typing of Haemophilus influenzae isolates non-typeable by agglutination].

Weltman G, Fossati MS, Correa C, Regueira M, Mollerach M.

Rev Argent Microbiol. 2005 Oct-Dec;37(4):199-202. Spanish.

PMID:
16502640
47.

Methicillin-resistant Staphylococcus aureus strains in Buenos Aires teaching hospitals: replacement of the multidrug resistant South American clone by another susceptible to rifampin, minocycline and trimethoprim-sulfamethoxazole.

Gardella N, Picasso R, Predari SC, Lasala M, Foccoli M, Benchetrit G, Famiglietti A, Catalano M, Mollerach M, Gutkind G.

Rev Argent Microbiol. 2005 Jul-Sep;37(3):156-60.

PMID:
16323667
48.

Biochemical characterization of the pneumococcal glucose 1-phosphate uridylyltransferase (GalU) essential for capsule biosynthesis.

Bonofiglio L, García E, Mollerach M.

Curr Microbiol. 2005 Oct;51(4):217-21. Epub 2005 Aug 16.

PMID:
16132460
49.

Transcriptional analysis of the bla(CTX-M-2) gene in Salmonella enterica serovar Infantis.

Di Conza JA, Gutkind GO, Mollerach ME, Ayala JA.

Antimicrob Agents Chemother. 2005 Jul;49(7):3014-7.

50.

Phenotypic and genotypic characterization of macrolide resistant Streptococcus pneumoniae recovered from adult patients with community-acquired pneumonia in an Argentinian teaching hospital.

Bonofiglio L, Ojeda MI, de Mier C, Vay C, Famiglietti A, Gutkind G, Mollerach M.

Int J Antimicrob Agents. 2005 Mar;25(3):260-3. Epub 2005 Jan 21.

PMID:
15737523

Supplemental Content

Loading ...
Support Center